Log In
BCIQ
Print this Print this
 

GBT009

  Manage Alerts
Collapse Summary General Information
Company Garnet Biotherapeutics Inc.
DescriptionBone marrow-derived somatic cells that secrete cytokines in response to inflammatory agents including tumor necrosis factor (TNF) alpha and interleukin-1 (IL-1) alpha
Molecular Target
Mechanism of ActionCell therapy
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationWounds
Indication DetailsTreat incisional wounds following breast reconstruction surgery; Treat post surgical wound repair, scar revisions and burns
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today